Taken together, these results indicate that ALKBH5-mediated m6A modification increases CASC8 levels in ESCC and that overexpression of CASC8 facilitates ESCC progression and chemoresistance to cisplatin by interacting with hnRNPL [107]. This evidence concerns the gene CASC8 and esophageal squamous cell carcinoma.